Authors: MEUNIER PJ CONFAVREUX E TUPINON I HARDOUIN C DELMAS PD BALENA R

Citation: Pj. Meunier et al., PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP), The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 2784-2791

Authors: MEUNIER PJ CONFAVREUX E TUPINON I HARDOUIN C DELMAS PD BALENA R

Citation: Pj. Meunier et al., PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP) (VOL 82, PG 2784, 1997), The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3740-3740

Authors: DELMAS PD HARDOUIN C CONFAVREUX E HARDY P BREMOND A

Citation: Pd. Delmas et al., INTERMITTENT RISEDRONATE PREVENTS BONE LOSS IN WOMEN WITH ARTIFICIAL MENOPAUSE INDUCED BY CHEMOTHERAPY OF BREAST-CANCER, Journal of bone and mineral research, 10, 1995, pp. 200-200

Authors: MEUNIER PJ CONFAVREUX E TUPINON I HARDOUIN C LOCKWOOD C BALENA R DELMAS PD

Citation: Pj. Meunier et al., CYCLICAL ETIDRONATE THERAPY PREVENTS BONE LOSS IN THE EARLY POSTMENOPAUSAL PERIOD, Journal of bone and mineral research, 10, 1995, pp. 357-357